UK Members of Parliament are criticizing Palantir after a report revealed the company gained access to identifiable NHS England patient information. Lawmakers described the decision as dangerous and questioned the priority of data privacy within the health service.
Palantir received this access as part of a £330 million contract to build the new Federated Data Platform. The move has intensified security concerns among patient groups and privacy campaigners.
An internal NHS briefing acknowledged considerable public interest and concern regarding Palantir's level of access. The Patients Association stated that officials failed to consult patients regarding this significant policy change.